Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy

T Tomson, D Battino, R Bromley, S Kochen… - Epileptic …, 2019 - shs.cairn.info
Management of epilepsy in pregnancy: a report from the International League Against Epilepsy
Task Force on Women and Pregnancy | Cairn.info Cairn.info, Matières à réflexion Cairn.info …

Epilepsy and pregnancy

Y Li, KJ Meador - CONTINUUM: Lifelong learning in neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW Seizure disorders are the most frequent major neurologic
complication in pregnancy, affecting 0.3% to 0.8% of all gestations. Women of childbearing …

Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability

MH Bjørk, H Zoega, MK Leinonen, JM Cohen… - JAMA …, 2022 - jamanetwork.com
Importance Women with epilepsy frequently need antiseizure medication (ASM) to prevent
seizures in pregnancy. Risk of neurodevelopmental disorders after prenatal exposure to …

Prenatal exposure to antiseizure medication and incidence of childhood-and adolescence-onset psychiatric disorders

JW Dreier, MH Bjørk, S Alvestad, M Gissler… - JAMA …, 2023 - jamanetwork.com
Importance Prenatal antiseizure medication (ASM) exposure has been associated with
adverse early neurodevelopment, but associations with a wider range of psychiatric end …

30 years of second-generation antiseizure medications: impact and future perspectives

E Perucca, MJ Brodie, P Kwan, T Tomson - The Lancet Neurology, 2020 - thelancet.com
Summary Since 1989, 18 second-generation antiseizure medications have reached the
market, resulting in a greatly increased range of treatment options for patients and …

Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM

AM Pack, M Oskoui, S Williams Roberson, DK Donley… - Neurology, 2024 - neurology.org
This practice guideline provides updated evidence-based conclusions and
recommendations regarding the effects of antiseizure medications (ASMs) and folic acid …

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and …

M Oskoui, T Pringsheim, L Billinghurst, S Potrebic… - Neurology, 2019 - neurology.org
Objective To provide updated evidence-based recommendations for migraine prevention
using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric …

Teratogenicity of antiepileptic drugs

T Tomson, D Battino, E Perucca - Current opinion in neurology, 2019 - journals.lww.com
The risk of adverse fetal effects differs in relation to the type of AED and for some AEDs also
the daily dose. Although for MCMs the risk is primarily associated with the first trimester of …

Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study

PB Pennell, A Karanam, KJ Meador, E Gerard… - JAMA …, 2022 - jamanetwork.com
Importance During pregnancy in women with epilepsy, lower blood concentrations of
antiseizure medications can have adverse clinical consequences. Objective To characterize …

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and …

M Oskoui, T Pringsheim, Y Holler-Managan, S Potrebic… - Neurology, 2019 - neurology.org
Objective To provide evidence-based recommendations for the acute symptomatic treatment
of children and adolescents with migraine. Methods We performed a systematic review of …